Trait drépanocytaire et tests du diabète : Ce que tout prestataire de soins de santé doit savoir

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Trait drépanocytaire et tests du diabète : Ce que tout prestataire de soins de santé doit savoir

[PDF-241.09 KB]

Details You May Also Like

Details:

Alternative Title:

Sickle cell trait and diabetes tests : what every healthcare provider should know [French]
Corporate Authors:

National Center on Birth Defect and Developmental Disabilities (Centers for Disease Control and Prevention (U.S.)). Division of Blood Disorders. ; Centers for Disease Control and Prevention (U.S.) ; American Society of Hematology. ; Sickle Cell Disease Association of America.

National Center on Birth Defect and Developmental Disabilities (Centers for Disease Control and Prevention (U.S.)). Division of Blood Disorders. ; Centers for Disease Control and Prevention (U.S.) ; American Society of Hematology. ; Sickle Cell Disease Association of America. Less -
Description:

Sickle cell trait and diabetes tests : what every healthcare provider should know [French]

Selon le National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), le test d’hémoglobine A1C peut ne pas être fiable pour diagnostiquer et surveiller le diabète et le prédiabète chez les individus porteurs du trait drépanocytaire (SCT) ou d’autres hémoglobinopathies. Afin d’offrir les meilleurs soins possibles à vos patients, il est important de déterminer leur statut au regard du trait drépanocytaire et de savoir si le test A1C auquel vous avez normalement recours doit être remplacé ou complété par un test différent.

CS303490-L French

Publication date from document properties.

sickle-cell-diabetes-HC-provid-fr-508-a.pdf
Subjects:

[+]

Anemia, Sickle Cell Anemia, Sickle Cell/diagnosis Anemia, Sickle Cell/genetics Hemoglobin, Sickle/analysis Hemoglobin A, Glycosylated/analysis Mass Screening/analysis
Document Type:

Pamphlet (or booklet)
Genre:

Fact Sheet
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:c866744d05d1c02d23eaf964af3fd94c964479ed92611a222973445c25cccffb
Download URL:

https://stacks.cdc.gov/view/cdc/112187/cdc_112187_DS1.pdf
File Type:

No Additional Files

More +

Trait drépanocytaire et tests du diabète : Ce que tout prestataire de soins de santé doit savoir

Details:

Supporting Files

You May Also Like